Merck & Co Inc (MRK) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 02 January 2026 | Trade in progress | 0.00% | |
| 01 February 2024 | 01 August 2024 | -8.66% | -16.6% |
| 02 May 2022 | 01 August 2023 | 19.38% | 15.24% |
| 04 January 2021 | 01 February 2021 | -4.67% | -46.39% |
| 01 October 2020 | 02 November 2020 | -7.07% | -57.85% |
| 01 June 2018 | 02 March 2020 | 38.14% | 20.27% |
| 02 May 2016 | 01 November 2017 | 5.29% | 3.5% |
| Total Return | 42.41% | ||
The monthly data for Merck & Co Inc (exchange: XNYS symbol: MRK) was last updated 13 Feb 2026 06:47. Data for this stock is available from 01 Dec 2015 - 12 Feb 2026.
